Acarbose Reduces Diabetes Risk in Coronary Heart Disease
Incidence of new-onset diabetes was 18% lower in the acarbose group than in the placebo group during a median of 4.4 years of follow-up.
Investigators sought to determine an association between diabetes and HbA1C with postoperative outcomes.
Overall, once-weekly semaglutide 1.0 mg as an add-on to basal insulin is the most efficacious GLP-1 receptor agonist in terms of reductions in HbA1c and body weight from baseline after ...
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.